Went to the Alfred today to do my bit, though I won't go into too much details, but all I'll say is after sitting through the entire process, I'm pretty confident that the company will be in a good position to resubmit for TGA approval once all the samples are collected. And I 'think' this time, our point of differences (compare to RATs) will really shine and be highlighted - especially on how samples are collected.
I'm glad the company and the TGA has finally worked out exactly how the trial should be ran, as it does seem like we are putting EuGeni through a stress test against PCR.
TO THE BOARD & CEO..... PLEASE EXPLAIN - Update your shareholders., page-156
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
-0.002(15.4%) |
Mkt cap ! $29.75M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.1¢ | $33.86K | 2.679M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2125960 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 6500 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| ADO (ASX) Chart |